PA2200 (Q9I1R7) review notes

Summary of the literature

PA2200 is a 531-aa protein with two predicted TM segments (20-39, 248-273 in
UniProt), a periplasmic region between them, and a C-terminal cytoplasmic EAL
domain (275-528). It has an intact EAL motif.

Literature search (Europe PMC, query "PA2200 AND aeruginosa", 2026-11-05; 18 hits,
mostly unrelated): the only primary data on PA2200 itself are in Kulesekara et al.
2006 (PMID:16477007). I read the full text on PMC (PMC1413825); the cached copy is
abstract-only. Verbatim excerpts:

PseudoCAP IBA-seed assessment

PTN node node term n_seeds leaf IBAs seed annotation (term, evidence, PMID) verdict rationale other seeds IBD stands without this seed?
PTN002105365 GO:0071111 cyclic-guanylate-specific phosphodiesterase activity 18 162 (24 taxa) GO:0071111, IDA, PMID:16477007 (PseudoCAP) SOUND Lysates of the overexpressing strain degraded 61% of added c-di-GMP compared with the vector control (full text read). The assay is crude, but the EAL motif is intact. E. coli PdeA/B/C/F/H/I/K/L/N, DosP; Mtb P9WM13; P. aeruginosa bifA, rocR, PA2133, nbdA, PA2567, PA3825 Yes. Node-level defects are recorded once in rocR-ai-review.yaml.

PA2200 is not a seed of PTN009140332, but it inherits its GO:1900190 IBA. The IBD
stands on bifA (see bifA and PA2133 notes). PA2200's own insertion mutant had no
biofilm phenotype.

Annotation decisions